WHO ICTRP trial

ProImmun Study- Influence of an endurance exercise program on the immune…

DRKS00004739 · German Clinical Trials Register · Recruiting

Key facts

Trial ID DRKS00004739
Public title ProImmun Study- Influence of an endurance exercise program on the immune function and quality of life of prostate cancer patients undergoing Antiandrogen- or Chemotherapy
Scientific title ProImmun Study- Influence of an endurance exercise program on the immune function and quality of life of prostate cancer patients undergoing Antiandrogen- or Chemotherapy - ProImmun Study
Primary sponsor Stiftung Leben mit Krebs
Registry German Clinical Trials Register
Recruitment status Recruiting
Study type interventional
Countries Germany
Conditions C61 G93.3;Malignant neoplasm of prostate;Postviral fatigue syndrome;G93.3
Interventions Group 1: Antiandrogentherapy + exercise, 5 Trainingsessions per week for 6 month. 2 sessions per week are supervised (35 min on a bycycle ergometer, 70-75% of the VO2peak) Group 2: Antiandrogentherapy without exercise Group 3: Chemotherapy…
Registration date May 3, 2013
Target size 80
Registry page drks.de

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations